scholarly journals Clinical outcomes in high‐hypoglycaemia‐risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first‐generation basal insulin analogue in the United States : Results from the DELIVER High Risk real‐world study

2021 ◽  
Author(s):  
Sean D. Sullivan ◽  
Nick Freemantle ◽  
Rishab A. Gupta ◽  
Jasmanda Wu ◽  
Charlie J. Nicholls ◽  
...  
Keyword(s):  
United States ◽  
Type 2 Diabetes ◽  
High Risk ◽  
Insulin Glargine ◽  
Real World ◽  
First Generation ◽  
Insulin Analogue ◽  
The United States ◽  
Risk Patients

scholarly journals Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States

2018 ◽  
Vol 31 (2) ◽  
pp. 129-137 ◽  
Author(s):  
Anita M. Loughlin ◽  
Qing Qiao ◽  
Anthony P. Nunes ◽  
Stephen M. Ezzy ◽  
Laura Yochum ◽  
...  
Keyword(s):  
United States ◽  
Type 2 Diabetes ◽  
Real World ◽  
Basal Insulin ◽  
The United States ◽  
Real World Setting
Sign in / Sign up

Export Citation Format

Share Document